Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients
- PMID: 39174791
- PMCID: PMC11341789
- DOI: 10.1038/s41598-024-70514-3
Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a pneumonia with extremely heterogeneous clinical presentation, ranging from asymptomatic to severely ill patients. Previous studies have reported links between the presence of host genetic variants and the outcome of the COVID-19 infection. In our study, we used whole exome sequencing in a cohort of 444 SARS-CoV-2 patients, admitted to hospital in the period October-2020-April-2022, to search for associations between rare pathogenic/potentially pathogenic variants and COVID-19 progression. We used gene prioritization-based analysis in genes that have been reported by host genetic studies. Although we did not identify correlation between the presence of rare pathogenic variants and COVID-19 outcome, in critically ill patients we detected known mutations in a number of genes associated with severe disease related to cardiovascular disease, primary ciliary dyskinesia, cystic fibrosis, DNA damage repair response, coagulation, primary immune disorder, hemoglobin subunit β, and others. Additionally, we report 93 novel pathogenic variants found in severely infected patients who required intubation or died. A network analysis showed main component, consisting of 13 highly interconnected genes related to epithelial cilium. In conclusion, we have detected rare pathogenic host variants that may have influenced the COVID-19 outcome in Bulgarian patients.
Keywords: COVID-19 severity and outcome; Cilia dysfunction; Host genetic variants; Rare protein-coding variants; SARS-CoV-2; WES.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
MeSH terms
Supplementary concepts
Grants and funding
- КP-06-DK1/8/2021/National Science Fund of Bulgarian Ministry of Education and Science; Bulgarian Ministry of Education and Science
- D01/ 285/2019/National Science Fund of Bulgarian Ministry of Education and Science; Bulgarian Ministry of Education and Science
- D01-395/2020/National Science Fund of Bulgarian Ministry of Education and Science; Bulgarian Ministry of Education and Science
- D01-302/2021/National Science Fund of Bulgarian Ministry of Education and Science; Bulgarian Ministry of Education and Science
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
